NMTC
Income statement / Annual
Last year (2025), NeuroOne Medical Technologies Corp's total revenue was $12.10 M,
an increase of 250.35% from the previous year.
In 2025, NeuroOne Medical Technologies Corp's net income was -$3.61 M.
See NeuroOne Medical Technologies Corp,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
09/30/2025 |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$12.10 M |
$3.45 M |
$1.95 M |
$171.17 K |
$178.15 K |
$1.93 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$3.96 M
|
$2.37 M
|
$1.50 M
|
$241.96 K
|
$275.90 K
|
$70.55 K
|
$27.57 K
|
$21.67 K
|
$17.63 K
|
$7.74 K
|
| Gross Profit |
$8.14 M
|
$1.08 M
|
$456.52 K
|
-$70.79 K
|
-$97.75 K
|
$1.86 M
|
-$27.57 K
|
-$21.67 K
|
-$17.63 K
|
-$7.74 K
|
| Gross Profit Ratio |
0.67
|
0.31
|
0.23
|
-0.41
|
-0.55
|
0.96
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$4.98 M
|
$5.07 M
|
$6.94 M
|
$4.93 M
|
$3.93 M
|
$2.08 M
|
$1.53 M
|
$951.06 K
|
$735.33 K
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$7.79 M
|
$6.75 M
|
$6.71 M
|
$5.92 M
|
$4.75 M
|
$4.28 M
|
$3.22 M
|
$2.34 M
|
$189.32 K
|
| Selling & Marketing Expenses |
$0.00
|
$108.99 K
|
$173.43 K
|
$270.61 K
|
$338.84 K
|
$0.00
|
$0.00
|
$322.84 K
|
$0.00
|
-$156.71 K
|
| Selling, General & Administrative Expenses |
$7.38 M
|
$7.90 M
|
$6.93 M
|
$6.98 M
|
$6.26 M
|
$4.75 M
|
$4.28 M
|
$3.54 M
|
$2.34 M
|
$32.61 K
|
| Other Expenses |
$0.00
|
$0.00
|
-$1.46 M
|
-$1.95 M
|
-$64.81 K
|
-$70.55 K
|
$0.00
|
-$1.30 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$12.37 M
|
$12.97 M
|
$12.41 M
|
$9.96 M
|
$10.12 M
|
$6.76 M
|
$5.81 M
|
$3.19 M
|
$3.07 M
|
$32.61 K
|
| Cost And Expenses |
$16.32 M
|
$15.34 M
|
$13.91 M
|
$10.20 M
|
$10.40 M
|
$6.83 M
|
$5.81 M
|
$3.21 M
|
$3.07 M
|
$32.61 K
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$334.06 K
|
$228.99 K
|
$0.00
|
$0.00
|
$3.05 K
|
$7.52 M
|
$284.56 K
|
$0.00
|
$1.40 M
|
$0.00
|
| Depreciation & Amortization |
$261.68 K
|
$246.79 K
|
$199.27 K
|
$118.62 K
|
$147.13 K
|
$70.55 K
|
$27.57 K
|
$21.67 K
|
$17.63 K
|
$7.74 K
|
| EBITDA |
-$3.01 M |
-$11.84 M |
-$11.66 M |
-$9.88 M |
-$9.80 M |
-$4.85 M |
-$5.79 M |
-$4.15 M |
-$3.05 M |
-$32.61 K |
| EBITDA Ratio |
-0.25
|
-3.43
|
-5.97
|
-57.73
|
-55
|
-2.52
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-0.35
|
-3.44
|
-6.12
|
-58.6
|
-57.36
|
-2.54
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$621.10 K
|
-$430.90 K
|
$95.76 K
|
$31.15 K
|
$270.04 K
|
-$8.74 M
|
-$967.77 K
|
-$2.66 M
|
-$1.99 M
|
$156.71 K
|
| Income Before Tax |
-$3.61 M
|
-$12.32 M
|
-$11.86 M
|
-$10.00 M
|
-$9.95 M
|
-$13.64 M
|
-$6.78 M
|
-$6.83 M
|
-$5.06 M
|
-$32.61 K
|
| Income Before Tax Ratio |
-0.3
|
-3.57
|
-6.07
|
-58.42
|
-55.84
|
-7.08
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.00
|
$0.00
|
$15.16 K
|
| Net Income |
-$3.61 M
|
-$12.32 M
|
-$11.86 M
|
-$10.00 M
|
-$9.95 M
|
-$13.64 M
|
-$6.78 M
|
-$6.83 M
|
-$5.06 M
|
-$47.78 K
|
| Net Income Ratio |
-0.3
|
-3.57
|
-6.07
|
-58.42
|
-55.84
|
-7.08
|
0
|
0
|
0
|
0
|
| EPS |
-0.54 |
-2.76 |
-3.9 |
-3.78 |
-5.58 |
-15.12 |
-10.32 |
-14.58 |
-13.8 |
-0.1698 |
| EPS Diluted |
-0.54 |
-2.76 |
-3.9 |
-3.78 |
-5.58 |
-15.12 |
-10.32 |
-14.58 |
-13.8 |
-0.1698 |
| Weighted Average Shares Out |
$6.69 M
|
$4.46 M
|
$3.02 M
|
$2.67 M
|
$1.78 M
|
$902.56 K
|
$658.75 K
|
$467.81 K
|
$367.23 K
|
$281.83 K
|
| Weighted Average Shares Out Diluted |
$6.69 M
|
$4.46 M
|
$3.02 M
|
$2.67 M
|
$1.78 M
|
$902.56 K
|
$658.75 K
|
$467.81 K
|
$367.23 K
|
$281.83 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
